Biologics

News Biologics

• Millipore Expands Drug Discovery and Development Services with BioAnaLab Acquisition

  Millipore Corporation announced it has acquired BioAnaLab, a European-based services provider that specializes in the analysis of biologic drugs and vaccines. The transaction enables Millipore to expand its biopharmaceutical services business into Europe and further strengthens its position as a pr more

• UK budget heralds price cuts on branded pharmaceuticals

  As part of the UK government’s drive to save £2.3 billion ($3.4 billion) in the National Health Service (NHS) during 2010–11, £550m ($800m) will be cut from the prices of branded drugs as a result of the revised Pharmaceutical Price Regulation Scheme (PPRS) included in Alistair Darling’s 2009 budget more

• IMS HEALTH Forecasts 4.5 - 5.5 Percent Growth for Global Pharmaceutical Market in 2009, Exceeding $820 Billion

  The global pharmaceutical market is expected to grow 4.5 - 5.5 percent next year, a pace similar to 2008, according to the IMS Global Pharmaceutical and Therapy Forecast™ released by IMS Health. The forecast predicts global pharmaceutical sales to surpass $820 billion in 2009, reflecting sustained d more

Publications Biologics

• Building Biologics by Chemical Synthesis: Practical Preparation of Di- and Triantennary N-Linked Glycoconjugates

  Journal of the American Chemical Society DOI: 10.1021/ja401385v more

• Kosmotrope-like Hydration Behavior of Polyethylene Glycol from Microcalorimetry and Binding Isotherm Measurements

  Polyethylene glycol (PEG) at various molecular weights (MWs) has been regarded as a wonder molecule in biomedical applications. For instance, PEG serves as a unique moiety for pegylation of “biobetter” drug development, PEG provides controlled-release and preserved activity of biologics, and PEG mod more

• Nanostructure-Mediated Transport of Biologics across Epithelial Tissue: Enhancing Permeability via Nanotopography

  Nano Letters DOI: 10.1021/nl3037799 more

Market studies Biologics

• Active Pharmaceutical Ingredients (API) Market in Europe to 2017 - Pricing and Reimbursement Initiatives Supporting Generic Drug Growth, with CMOs Expected to Account for Major ...

  GBI Research’s report, “Active Pharmaceutical Ingredients (API) Market in Europe to 2017 - Pricing and Reimbursement Initiatives Supporting Generic Drug Growth, with CMOs Expected to Account for Majority of the Manufacturing Activity” provides detailed insight into the Europe API market. The researc more

Websites Biologics